Risk factors for early and late cholecystitis after covered metal stent placement for distal biliary obstruction

Abstract

AbstractBackgroundCholecystitis is a major adverse event after self‐expandable metallic stent placement for distal biliary obstruction (DBO). Covered self‐expandable metallic stent (CSEMS) is being increasingly used, but few studies have investigated risk factors for cholecystitis limited to CSEMS. The present study aimed to identify risk factors for cholecystitis after CSEMS.MethodsPatients who underwent initial CSEMS placement for DBO between November 2014 and September 2021 were enrolled and followed‐up until death, recurrent biliary obstruction, cholecystitis, or until March 2022. Cholecystitis within 30 days of CSEMS was defined as early cholecystitis and after 30 days as late cholecystitis.ResultsCholecystitis occurred in 51 of 339 patients (15%) after CSEMS. Forty‐one patients (80.4%) had early cholecystitis, and 10 (19.6%) had late cholecystitis. Multivariate logistic regression analysis revealed that the maximum diameter of the common bile duct (CBD) (per 1 mm increase) (odds ratio [OR]: 0.87; 95% confidence interval [CI]: 0.76–1.00; p = .044), gallbladder stones (OR: 3.63; 95% CI: 1.62–8.10; p = .002), and tumor involvement in the cystic duct (CD) (OR: 4.87; 95% CI: 2.16–11.00; p < .001) were significant independent risk factors associated with early cholecystitis. No significant risk factors were identified for late cholecystitis.ConclusionsA smaller CBD diameter, gallbladder stones, and tumor involvement in the CD were identified as risk factors for early cholecystitis development after CSEMS.